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Summary
. A total of 917 children and young people under 18
years with established renal failure (ERF) were
receiving treatment at paediatric nephrology centres
in 2014.
. At the census date (31st December 2014), 79.3% of
prevalent paediatric patients aged ,18 years had a
functioning kidney transplant, 11.2% were receiving
haemodialysis (HD) and 9.5% were receiving peri-
toneal dialysis (PD).
. In patients aged ,16 years, prevalence of ERF was
60.4 per million age related population (pmarp)
and the incidence 9.4 pmarp.
. The most common primary renal diagnosis was
renal dysplasia+ reﬂux, present in 32.6% of preva-
lent paediatric patients aged ,16 years.
. About a third of patients had one or more reported
comorbidity at onset of renal replacement therapy
(RRT).
. The improvement in rates of pre-emptive transplan-
tation for those referred early has been maintained
over the last 10 years at 37.5%, compared to 27.4%
in 2000–2004.
. At transfer to adult services, 90.3% of patients had a
functioning kidney transplant.
. Survival during childhood amongst children com-
mencing RRT was the lowest in those aged less
than two years compared to those aged 12 to less
than 16 years with a hazard ratio of 4.1 (conﬁdence
interval 2.2–8.0), and in those receiving dialysis
compared to having a functioning transplant with
a hazard ratio of 6.3 (conﬁdence interval 3.9–10.2).
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Introduction
The UK Renal Registry (UKRR) publishes an annual
report detailing demographics, clinical, haematological
and biochemical parameters for patients managed in
UK paediatric nephrology centres. In the UK, care for
children, adolescents and young adults with established
renal failure (ERF) requiring renal replacement therapy
(RRT) is a tertiary service provided in 13 paediatric
nephrology centres. All centres are equipped to provide
peritoneal dialysis (PD) and haemodialysis (HD), with
10 centres also undertaking kidney transplantation.
Young adults aged 16–18 may be managed in either
paediatric or adult services, depending on local practices,
educational and social factors. In this report, data for all
patients aged under 18 years in UK paediatric nephrology
centres reported to the UKRR with a particular focus
on the demographics of those aged 16 and under are
described.
In the UK in 2013, the prevalence rate of treated
ERF in children aged under 16 years was 58.2 and the
incidence rate was 9.3 per million age related population
(pmarp) [1].
The objectives of this report are:
(i) To describe the UK prevalence, incidence, causes
of ERF and modality of treatment of children,
adolescents and young adults on RRT on 31st
December 2014
(ii) To describe trends in (i) over the past 15 years,
and
(iii) To describe pre-emptive transplantation rates and
survival of children, adolescents and young adults
on RRT aged ,16 years old in the UK.
All 13 paediatric nephrology centres in the UK con-
tributed data to the UKRR, mandated in England by
the NHS service speciﬁcation which requires ‘paediatric
renal units to submit data comprising the national renal
data set to the UK Renal Registry on all patients on
renal replacement therapy’ [2]. In most cases this is via
an annual extract of a centre’s clinical computer system
which is checked, validated and loaded onto the UKRR
paediatric database. Where this is not possible, data
returns are completed using a data collection form and
manually loaded. At each return, missing data items are
sought. Centres pay a capitation fee in order to support
the process. Currently, the UKRR paediatric and adult
databases are maintained separately and a future merger
is planned.
Methods
Centres arranged for their own data to be extracted and sent to
the UKRR for processing by clinical informaticians. For this
report, end of year numbers were required by the 31st January
2015 and the full data by the 31st March 2015, however, the last
submission was received on the 3rd August 2015. Overall
responsibility for the process is held by the Chair of the British
Association for Paediatric Nephrology (BAPN) Audit & Registry
Committee.
The content and analyses contained in the paediatric chapters
are discussed and agreed by the BAPN Audit & Registry Commit-
tee members.
In this report, patient groups are described as:
(i) ‘prevalent’ group: patients who were receiving RRT on the
31st December 2014
(ii) ‘incident’ group: patients who started RRT between 1st
January and 31st December 2014
(iii) ‘5 year’ groups: patients who started RRT in the periods of
2000–2004, 2005–2009 and 2010–2014.
The populations used to calculate the incidence and prevalence
were obtained from the Ofﬁce for National Statistics (ONS) [3].
The mid-2014 population estimate produced by the ONS, based
on the 2011 Census, was used to calculate the 2014 incidence
and prevalence; the 2002 Census data used for the 2000–2004
group, the 2007 data for the 2005–2009 group and the 2012
data for the 2010–2014 group. Incidence and prevalence for 16–
18 year olds are not reported. This is because data would not be
representative of the UK as a whole as they may also be managed
in adult services.
Statistical analyses were performed using SAS 9.3, with group
analyses using the Chi-square test and median analyses using
the Kruskal-Wallis test. Infants under the age of three months
and ‘late presenters’ (deﬁned as those commencing dialysis within
three months following ﬁrst review by a paediatric nephrologist)
were excluded from analyses when calculating pre-emptive trans-
plantation rates. For survival analysis, only patients starting RRT
between 1st January 2000 and 31st December 2013 were included
to ensure a minimum of one year follow up at the census date, and
were followed up to a maximum age of 16 years. As the maximum
age of follow up was restricted to 16 years it was not possible to
calculate 10 year survival probabilities for patients starting RRT
aged .8 years, or 5 year survival probability for children starting
RRT aged .12 years. A Cox regression model was used in
calculating hazard ratios for patient survival, adjusting for gender,
age at start of RRT, and RRT modality as a time dependent
variable. Survival probabilities were calculated using univariate
Kaplan Meier curves.
Results
Data returns
Centres used a variety of clinical data systems to
facilitate returns. In 2014, the majority of paediatric
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renal centres were using Vitaldata (Birmingham, Cardiff,
Glasgow, Leeds, London Great Ormond Street) with
others using Proton (Bristol, Nottingham), Clinicalvision
(Manchester, Newcastle), Mediqal (Belfast), CyberREN
(Liverpool) or bespoke systems (London Evelina,
Southampton).
In 2014, most centres submitted data electronically
(n = 12) to the UKRR via extracts. The remaining centre
used paper forms which were manually entered into the
database.
Overall data completeness was excellent for the follow-
ing: age and gender (100%), ethnicity (98.0%), start and
90 day treatment modality (99.7%) and start date
(99.5%). Completeness of other data items ranged from
84.1% to 97.8% and is shown by centre in table 4.1.
Centre size and type (if undertaking paediatric kidney
transplantation) is also displayed.
The UK paediatric prevalent ERF population in 2014
A total of 917 children and young people under 18
years with ERF were receiving treatment at paediatric
nephrology centres in 2014 (table 4.1). Of these, 734
were under 16 years of age. Table 4.2 shows the number
of patients receiving RRT and rate of RRT by age group
and gender. There were more than ten times the number
of teenagers than infants receiving RRT. The prevalence
of RRT increased with age and was higher in males across
all age groups with an overall male to female ratio of
1.7 : 1. The reported prevalence in under 16 year olds
was 60.4 pmarp.
Table 4.3 shows the prevalence of childhood ERF by
ethnicity. Children from ethnic minorities displayed
higher RRT prevalence rates when compared with
White children, with South Asian children displaying
the highest rates.
Table 4.1. Data completeness for the paediatric prevalent ERF population in 2014
Percentage completeness
Centre N
First seen
date
Height at
RRT start
Weight at
RRT start
Creatinine at
RRT start
Primary renal
diagnosis
Blfst_P∗ 30 90.0 76.7 83.3 90.0 96.7
Bham_P∗ 103 98.1 93.2 97.1 97.1 100.0
Brstl_P∗ 57 94.7 89.5 94.7 96.5 100.0
Cardf_P 28 100.0 100.0 100.0 100.0 100.0
Glasg_P∗ 56 100.0 96.4 100.0 100.0 100.0
L Eve_P∗ 99 98.0 69.7 75.8 77.8 100.0
L GOSH_P∗ 185 96.8 87.0 94.1 95.1 93.0
Leeds_P∗ 86 100.0 90.7 100.0 100.0 100.0
Livpl_P 41 87.8 70.7 75.6 85.4 87.8
Manch_P∗ 85 95.3 89.4 96.5 96.5 100.0
Newc_P∗ 37 100.0 100.0 100.0 100.0 100.0
Nottm_P∗ 85 100.0 60.0 71.8 90.6 98.8
Soton_P 25 100.0 72.0 72.0 84.0 100.0
UK 917 97.3 84.1 90.2 93.5 97.8
∗Denotes centres undertaking paediatric kidney transplantation
Table 4.2. The UK paediatric prevalent ERF population ,16 years old in 2014, by age group
All patients Males Female
M : F rate
Age group (years) N pmarp N pmarp N pmarp ratio
0–,2 23 14.6 15 18.5 8 10.4 1.8
2–,4 49 29.8 35 41.5 14 17.4 2.4
4–,8 163 51.3 107 65.9 56 36.1 1.8
8–,12 214 73.8 140 94.4 74 52.3 1.8
12–,16 285 99.8 169 115.6 116 83.2 1.4
Under 16 734 60.4 466 74.9 268 45.2 1.7
pmarp – per million age related population
Demography of renal replacement therapy
in paediatric patients
Nephron 2016;132(suppl1):99–110 101
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f B
ris
to
l  
   
   
   
   
   
   
   
   
   
   
  
13
7.
22
2.
12
0.
22
6 
- 6
/8
/2
01
6 
1:
27
:4
6 
PM
Modality of treatment
The majority of prevalent paediatric patients under 16
years old in 2014 had a functioning transplant, as shown
in ﬁgure 4.1. The ratio of living to deceased donor trans-
plants was 1 : 1.
Almost half of patients started RRT on PD, similar
proportions started with a pre-emptive transplant or on
HD, as displayed in ﬁgure 4.2.
Analysis by age shows the proportion of those receiv-
ing dialysis as current treatment is lower in older children
with increasing use of transplantation (particularly from
deceased donors) in older patients, as seen in table 4.4.
Table 4.3. The UK paediatric prevalent ERF population ,16 years old by age and ethnic groupa in 2014
White South Asian Black Otherb
Age group (years) N pmarp N pmarp N pmarp N
0–,4 51 19.7 8 37.9 2 23.7 8
4–,8 110 46.0 31 158.9 4 51.3 16
8–,12 148 57.9 38 182.3 11 131.9 12
12–,16 206 76.5 45 204.9 14 159.4 17
Under 16 515 50.3 122 146.3 31 92.9 53
pmarp – per million age related population
aethnicity data missing for 13 children, not included in this table
bpmarp not expressed for group ‘Other’, as heterogeneous group
Haemodialysis
13%
Peritoneal dialysis
11%
Deceased donor
transplant
36%
Live transplant
40%
Fig. 4.1. RRT treatment used by prevalent paediatric patients
,16 years old in 2014
Haemodialysis
32%
Peritoneal dialysis
44%
Deceased donor
transplant
9%
Live transplant
15%
Fig. 4.2. Treatment modality at start of RRT in prevalent paedia-
tric patients ,16 years old in 2014
Table 4.4. Current treatment modality by age in the prevalent paediatric ERF population in 2014
Age group
(years) Total
Current treatment
HD PD Live transplant Deceased donor transplant
N % N % N % N %
0–,2 23 8 34.8 13 56.5 2 8.7 0 0.0
2–,4 49 19 38.8 13 26.5 13 26.5 4 8.2
4–,8 163 21 12.9 16 9.8 90 55.2 36 22.1
8–,12 214 22 10.3 15 7.0 93 43.5 84 39.3
12–,16 285 23 8.1 25 8.8 99 34.7 138 48.4
16–,18 183 10 5.5 5 2.7 76 41.5 92 50.3
Under 16 734 93 12.7 82 11.2 297 40.5 262 35.7
Under 18 917 103 11.2 87 9.5 373 40.7 354 38.6
HD – haemodialysis; PD – peritoneal dialysis
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Treatment in the youngest age groups is subject to
variation as there were few patients. There was no differ-
ence in modality by gender. There was signiﬁcantly
higher transplantation in Whites versus non-Whites
(p = 0.001).
Cause of ERF
Renal dysplasia with or without reﬂux nephropathy
was the commonest primary renal diagnosis (PRD) in
prevalent patients under 16 years in 2014, shown in
table 4.5. The high male to female ratio in those with
obstructive uropathy was a result of posterior urethral
valves. Figure 4.3 displays the percentage of patients in
each diagnostic category for incident and prevalent
cohorts, and shows a disproportionately high amount
of uncertain diagnoses in incident compared to prevalent
patients, although the absolute numbers are small here.
Missing PRD data has increased from 0.4% in 2011 [4]
to 2.0% in 2014, some of which may be due to a PRD
not being assigned until the results of genetic tests have
been received.
The commonest comorbidities at the onset of RRT in
2014 were congenital abnormalities, developmental delay
and syndromic diagnoses, reported in 7.5% of patients
respectively, shown in table 4.6. Although the majority
of children are reported to have no comorbidities, there
was considerable variation between centres (e.g. no
Table 4.5. Number, percentage and gender by primary renal disease in the prevalent paediatric ERF population under 16 years in 2014
Diagnostic group Total % Male Female M : F ratio
Renal dysplasia+ reﬂux 239 32.6 153 86 1.8
Obstructive uropathy 135 18.4 131 4 32.8
Glomerular disease 79 10.8 37 42 0.9
Congenital nephrotic syndrome 69 9.4 37 32 1.2
Tubulo-interstitial disease 51 6.9 22 29 0.8
Uncertain aetiology 38 5.2 20 18 1.1
Renovascular disease 32 4.4 22 10 2.2
Polycystic kidney disease 31 4.2 13 18 0.7
Metabolic 29 4.0 17 12 1.4
Malignancy & associated disease 16 2.2 4 12 0.3
Missing 15 2.0 10 5 2.0
Total 734 466 268 1.7
0  10  20  30  40
Percentage of patients
Renal dysplasia + reflux
Obtructive uropathy
Glomerular disease
Congenital nephrotic
syndrome
Tubulo-interstitial disease
Renovascular disease
Polycystic kidney disease
Drug nephrotoxicity
Metabolic
Uncertain aetiology
Malignancy &
associated disease
Pr
im
ar
y 
re
na
l d
is
ea
se
Prevalent
Incident
Fig. 4.3. Primary renal disease percentage in incident and preva-
lent paediatric patients in 2014 for whom a causative diagnosis was
reported
Table 4.6. Frequency of registered comorbidities at onset of
RRT in prevalent paediatric patients aged ,16 years with ERF
in 2014
Comorbidity N
Percentage of all
RRT patients
Congenital abnormality 55 7.5
Developmental delay 55 7.5
Syndromic diagnosis 55 7.5
Prematurity 42 5.7
Consanguinity 30 4.1
Chromosomal abnormality 12 1.6
Liver disease 12 1.6
Congenital heart disease 9 1.2
Family member with ERF 9 1.2
Cerebral palsy 8 1.1
Malignancy 6 0.8
Neural tube defect 4 0.5
Psychological disorder 4 0.5
Diabetes 1 0.1
No reported comorbidity 528 71.9
One reported comorbidity 136 18.5
Two or more comorbidities 70 9.5
RRT – renal replacement therapy; ERF – established renal failure
Demography of renal replacement therapy
in paediatric patients
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comorbidity reported in 92% of patients from Cardiff,
and 40% of patients from Manchester). This may be
due to small numbers in some centres or reporting prac-
tice and is subject to a current data quality exercise in
order to evaluate whether there are genuine differences
between centres in willingness to accept patients with
comorbidity onto the RRT programme.
The UK incident paediatric ERF population in 2014
There were 120 patients under 18 years of age who
commenced RRT at paediatric renal centres in 2014. As
previously, the following analyses are restricted to the
114 patients who were under 16 years of age.
The incidence of RRT was 9.4 pmarp in 2014. Patients
commencing RRT in 2014 are displayed by age and
gender in table 4.7, although any apparent differences
may be a result of small group sizes.
Table 4.8 shows that the reported incidence of RRT
has remained steady since 2000, with the highest
incidence seen in both the youngest and oldest age
groups.
Trends in ERF demographics
There were 1,697 children and adolescents under 16
years of age who had received RRT in the UK over the
15 year period between 2000 and 2014. Table 4.9 demon-
strates slight ﬂuctuations over time in the ages of patients
starting RRT. Table 4.10 shows overall ethnicity pro-
portions are similar, with slightly more in the ‘Other’
ethnic group and slightly fewer in the White group
more recently. Table 4.11 demonstrates that the overall
proportions between paediatric renal centres have
remained largely unchanged since 2000–2004.
Table 4.12 shows the number and percentage of
children receiving RRT with each of the major reported
comorbidities over the last 15 years. As before, any appar-
ent differences may be as a result of small numbers
Table 4.7. The incident paediatric ERF population ,16 years old in the UK in 2014, by age group and gender
Age group (years)
All patients Males Females
M : F ratioN pmarp N pmarp N pmarp
0–,2 14 8.9 10 12.4 4 5.2 2.4
2–,4 17 10.3 10 11.9 7 8.7 1.4
4–,8 25 7.9 18 11.1 7 4.5 2.5
8–,12 25 8.6 21 14.2 4 2.8 5.0
12–,16 33 11.6 18 12.3 15 10.8 1.1
Under 16 114 9.4 77 12.4 37 6.2 2.1
pmarp – per million age related population
Table 4.8. Reported average incidence by age group in 5-year
time periods of children under 16 years of age commencing
RRT
Age group
(years)
Per million age related population
2000–2004 2005–2009 2010–2014
0–,2 10.9 14.6 11.8
2–,4 6.4 6.7 9.0
4–,8 5.5 7.5 6.1
8–,12 8.8 8.8 9.0
12–,16 12.7 14.8 11.7
Under 16 9.0 10.6 9.3
Table 4.9. Number and percentage of children ,16 years old who commenced RRT by age group and 5-year period at start of RRT
Age group (years)
2000–2004 2005–2009 2010–2014
N % N % N %
0–,2 72 13.6 109 17.9 96 17.2
2–,4 44 8.3 48 7.9 71 12.7
4–,8 80 15.1 101 16.6 92 16.5
8–,12 136 25.7 127 20.9 125 22.4
12–,16 198 37.4 224 36.8 174 31.2
16 530 609 558
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Table 4.10. Number∗ and percentage of children under 16 years who commenced RRT, by ethnicity and 5-year period of starting RRT
Ethnic group
2000–2004 2005–2009 2010–2014
N % N % N %
White 407 77.2 451 75.2 378 69.4
South Asian 87 16.5 98 16.3 97 17.8
Black 13 2.5 25 4.2 20 3.7
Other 20 3.8 26 4.3 50 9.2
Under 16 years 527 600 545
∗Three children in 2000–2004, nine in 2005–2009 and 13 in 2010–2014 with no ethnicity recorded are excluded from this table
Table 4.11. Number and percentage of children under 16 years by renal centre and 5-year period of starting RRT
Centre
2000–2004 2005–2009 2010–2014
N % N % N %
Blfst_P 15 2.8 19 3.1 20 3.6
Bham_P 51 9.6 66 10.8 63 11.3
Brstl_P 38 7.2 33 5.4 36 6.5
Cardf_P 15 2.8 20 3.3 22 3.9
Glasg_P 34 6.4 50 8.2 36 6.5
L Eve_P 53 10.0 65 10.7 56 10.0
L GOSH_P 91 17.2 124 20.4 103 18.5
Leeds_P 47 8.9 56 9.2 51 9.1
Livpl_P 29 5.5 26 4.3 19 3.4
Manch_P 60 11.3 48 7.9 62 11.1
Newc_P 28 5.3 26 4.3 22 3.9
Nottm_P 48 9.1 63 10.3 49 8.8
Soton_P 21 4.0 13 2.1 19 3.4
Total <16 530 609 558
Table 4.12. Trends in reported comorbidity frequency at the start of RRT in the paediatric population under 16 years by 5-year period
Comorbidity
2000–2004 2005–2009 2010–2014
N % N % N %
Syndromic diagnosis 41 7.7 53 8.7 39 7.0
Developmental delay 44 8.3 44 7.2 36 6.5
Congenital abnormality 44 8.3 57 9.4 30 5.4
Prematurity 27 5.1 31 5.1 28 5.0
Consanguinity 25 4.7 18 3.0 23 4.1
Family member with ERF 19 3.6 15 2.5 11 2.0
Liver disease 7 1.3 12 2.0 8 1.4
Neural tube defect 0 6 1.0 6 1.1
Psychological disorder 11 2.1 7 1.1 6 1.1
Cerebral palsy 10 1.9 11 1.8 5 0.9
Congenital heart disease 10 1.9 23 3.8 4 0.7
Malignancy 8 1.5 4 0.7 3 0.5
Chromosomal abnormality 17 3.2 19 3.1 2 0.4
Diabetes 6 1.1 3 0.5 0
No reported comorbidity 338 63.8 415 68.1 417 74.7
One reported comorbidity 137 25.8 123 20.2 96 17.2
Two or more comorbidities 55 10.4 71 11.7 45 8.1
ERF – established renal failure
Demography of renal replacement therapy
in paediatric patients
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between groups. Overall there is a trend towards the
reporting of less comorbidity in children receiving RRT
over the last 15 years and as previously mentioned, it is
not clear whether this is due to reporting or differences
in case selection.
The continued fall in the use of deceased donor trans-
plants at the start of RRT demonstrated in previous
reports [1] appears to have stabilised as seen in ﬁgure 4.4,
with little change between the most recent ﬁve year
periods. Use of PD as a start modality has fallen from
54% in 2000–2004 to 38% in 2010–2014, being replaced
with increasing use of HD and living kidney donation.
Glomerular disease as a cause of ERF has fallen com-
pared to other PRDs in the prevalent paediatric population
over the last ﬁfteen years, as shown in table 4.13.
Pre-emptive transplantation
Of a total of 1,697 patients aged 0–16 years who started
RRT between 2000 and 2014, 465 patients were excluded
from this analysis (95 patients due to being aged
,3 months, 369 due to being late presenters, and one
additional patient with unclear dates). Of 1,232 patients
identiﬁed as being aged three months to ,16 years and
having started RRT between 2000–2014, table 4.14 shows
that a third of patients had a pre-emptive transplant.
There was a signiﬁcant difference in pre-emptive
transplantation rates by time period (higher rates more
recently, p = 0.005), with similar rates between the two
most recent ﬁve year periods.
There remained a signiﬁcant difference in pre-emptive
transplantation rates with higher rates in boys ( p = 0.01),
Haemodialysis Peritoneal dialysis Deceased donor
transplant
Live transplant
Modality
Pe
rc
en
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2010–2014
Fig. 4.4. Treatment modality at start of RRT
by 5-year time period
Table 4.13. Number∗ and percentage of primary renal diseases in prevalent paediatric patients under 16 years by 5-year time period
Primary renal diagnosis
2000–2004 2005–2009 2010–2014
N % N % N %
Renal dysplasia+ reﬂux 159 30.4 194 32.4 182 33.6
Obstructive uropathy 77 14.7 83 13.9 98 18.1
Glomerular disease 119 22.8 122 20.4 68 12.6
Congenital nephrotic syndrome 24 4.6 36 6.0 36 6.7
Tubulo-interstitial disease 43 8.2 49 8.2 43 7.9
Uncertain aetiology 14 2.7 35 5.8 39 7.2
Renovascular disease 25 4.8 20 3.3 16 3.0
Polycystic kidney disease 14 2.7 18 3.0 24 4.4
Metabolic 28 5.4 29 4.8 30 5.5
Malignancy & associated disease 10 1.9 9 1.5 5 0.9
Drug nephrotoxicity 10 1.9 4 0.7 0 0.0
∗Seven children in 2000–2004, 10 in 2005–2009 and 17 in 2010–2014 with no primary renal diagnosis recorded are excluded from this table
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although this difference was not signiﬁcant when adjusted
for other factors in a logistic regression. Pre-emptive trans-
plantation rates were higher in White versus non-White
ethnicity (p, 0.0001). Rates also differed with PRD
(lower in glomerular diseases versus renal dysplasia+
reﬂux nephropathy and obstructive uropathies, p,
0.0001). Children with polycystic kidney disease, obstruc-
tive uropathy, renal dysplasia+ reﬂux, metabolic causes
and renovascular diseases had the highest rates of pre-
emptive transplantation, whilst those with congenital
nephrotic syndrome had the lowest rate.
Analysis by age at start of RRT showed that as
expected, the lowest rate of pre-emptive transplantation
was in the three months to two year group, whilst
children aged four to sixteen years all had similar rates
of pre-emptive transplantation. Following exclusion of
the youngest age group, there was no difference in pre-
emptive transplantation rates by age.
Transfer of patients to adult renal services in 2014
Ninety three patients were reported by paediatric
nephrology centres to have transferred to adult renal
services in 2014, fairly consistent with the 101 who
transferred during 2013 [1]. The median age of patients
transferred out was 18.1 years with an inter-quartile
range of 17.8 to 18.5 years. Table 4.15 shows that the
demographics of those transferring out were very similar
to that of the overall prevalent paediatric RRT population,
but with over 90% having a functioning transplant.
Survival of children on RRT during childhood
Of patients under 16 years of age, 1,583 were identiﬁed
as starting RRT between 2000 and 2013 at paediatric
centres in the UK and were included in the survival
Table 4.14. Demographic characteristics of pre-emptive trans-
plantation in children aged three months to 16 years in the UK
between 2000–2014, analysed by 5-year time period, gender,
ethnicity, age at start of RRT and primary renal diagnosis
N
N (%)
pre-emptively
transplanted
Total cohort analysed (2000–2014) 1,232 417 (33.8)
Time period
2000–2004 390 107 (27.4)
2005–2009 426 154 (36.2)
2010–2014 416 156 (37.5)
Gender
Male 773 282 (36.5)
Female 459 135 (29.4)
Ethnicity
White 899 330 (36.7)
South Asian 209 47 (22.5)
Black 39 6 (15.4)
Other 62 23 (37.1)
Age at start of RRT (years)
3 months–,2 123 7 (5.7)
2–,4 137 38 (27.7)
4–,8 220 88 (40)
8–,12 304 110 (36.2)
12–,16 448 174 (38.8)
Primary renal diagnosis
Renal dysplasia+ reﬂux 410 173 (42.2)
Obstructive uropathy 217 101 (46.5)
Glomerular disease 205 25 (12.2)
Congenital nephrotic syndrome 81 4 (4.9)
Tubulo-interstitial disease 76 17 (22.4)
Metabolic 74 31 (41.9)
Polycystic kidney disease 46 23 (50)
Uncertain aetiology 39 11 (28.2)
Renovascular disease 37 15 (40.5)
Malignancy & associated disease 15 1 (6.7)
Drug nephrotoxicity 6 1 (16.7)
Table 4.15. Modality, gender, ethnicity and primary renal
diagnosis of patients transferred out from paediatric nephrology
centres to adult renal services in 2014
N %
Modality
Transplant 84 90.3
HD 6 6.5
PD 3 3.2
Gender
Male 53 57.0
Female 40 43.0
Ethnicity
White 63 67.7
South Asian 15 16.1
Other 9 9.7
Black 6 6.5
Primary renal diagnosis
Renal dysplasia+ reﬂux 28 30.1
Glomerular disease 27 29.0
Obstructive uropathy 13 14.0
Tubulo-interstitial disease 10 10.8
Congenital nephrotic syndrome 4 4.3
Polycystic kidney disease 4 4.3
Metabolic 3 3.2
Uncertain aetiology 2 2.2
Malignancy & associated disease 1 1.1
Renovascular disease 1 1.1
Drug nephrotoxicity 0
HD – haemodialysis; PD – peritoneal dialysis
Demography of renal replacement therapy
in paediatric patients
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analyses. At the census date (31st December 2014) there
were a total of 99 deaths reported in children on RRT
under 16 years of age at paediatric centres. The median
follow up time was 3.5 years (range of 1 day to 14.5
years). Table 4.16 shows the survival hazard ratios (fol-
lowing adjustment for age at start of RRT, gender and
RRT modality) and highlights that children starting
RRT under two years of age had the worst survival out-
comes with a hazard ratio of 4.1 (conﬁdence interval
(CI) 2.2–8.0, p , 0.0001) when compared to 12–16 year
olds. Being on dialysis was seen to lower survival signiﬁ-
cantly compared to having a functioning transplant with
a hazard ratio of 6.3 (CI 3.9–10.3, p , 0.0001). There was
insufﬁcient power to add PRD to the model; drug
induced nephrotoxicity and metabolic PRDs had the
worst survival but conﬁdence intervals were wide and
included no effect. Figure 4.5 shows unadjusted Kaplan
Meier (KM) survival probabilities and highlights worse
outcomes for those aged less than two years, particularly
during the ﬁrst year.
Mortality data in 2014
Six deaths occurred in paediatric renal centres in 2014;
four were in patients aged under two years and two were
in 15 year olds. The median age at death was 1.5 years
with a range of 0.4 years to 15.9 years. In children aged
,16 years with treated ERF, the total reported mortality
in 2014 in UK paediatric centres was 0.8% (6/734), and
2.9% (5/175) for those on dialysis.
Transplant deaths
At the time of death, one adolescent had received a
kidney transplant. The cause of death was intractable sei-
zures in the context of a previously undiagnosed mito-
chondrial disorder.
Dialysis deaths
At the time of death, three children were on dialysis
(two HD and one PD). One HD patient died as a result
of substance abuse on a background of poor compliance,
and the second had a sudden unexplained death. Infec-
tion was the cause of death in the PD patient. Two further
children died whilst receiving active palliative care, both
having withdrawn from PD.
Table 4.16. Survival hazard ratio during childhood for paedia-
tric RRT patients aged ,16 years in the UK adjusted for age at
start of RRT, gender and RRT modality
Hazard
ratio
Conﬁdence
interval p-value
Age (years)
0–,2 4.1 2.2–8.0 ,0.0001
2–,4 2.1 1.0–4.3 0.06
4–,8 2.0 0.9–4.1 0.08
8–,12 1.4 0.6–3.1 0.5
12–,16 1.0 –
Gender
Female 1.2 0.7–1.8 0.5
Male 1.0 –
RRT modality
Dialysis 6.3 3.9–10.2 ,0.0001
Transplant 1.0 –
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Fig. 4.5. Unadjusted KM survival in
paediatric patients ,16 years old starting
RRT between 2000 and 2013, by age at start
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Discussion
This report provides the paediatric nephrology com-
munity with a unique resource of data on the demo-
graphics of the UK paediatric RRT population from the
previous year, as well as allowing comparison of trends
over the last ﬁfteen years. This information is vital for
commissioning of such a tertiary service, and data is
also contributed to European registry reports to allow
for international comparisons.
Data returns
Paediatric nephrology in the UK faces the challenge of
being mandated to submit electronic data on small
numbers of patients to the UKRR, sometimes in the
context of being ‘shoehorned’ into using renal computer
systems designed to collect registry data for adult
patients. This often results in the need for additional
data collection for the paediatric-speciﬁc dataset. Unsur-
prisingly, submission of data to the UKRR remained
variable. Improved infrastructure, funding and famili-
arity with extraction procedures are required, and when
staff or computer systems change fresh investment by
centres is needed to successfully manage the process.
Issues are faced when centres lack ﬁnancial resources
for a renal computer system that supports UKRR speciﬁc
data collection, or there is not widespread use of such
systems by clinical staff. This year, the majority of 2014
data returns breached the target submission date which
affects the UKRR’s ability to produce the Annual Report
on time. In spite of this all centres are included. Despite a
standardised dataset, the extracts received by the UKRR
usually required extensive manipulation to allow them
to be uploaded into the database. Once submitted data
has been checked and validated they are returned to
submitting renal centres with the onus on clinicians to
provide any missing data items. A system is being devised
to mark unobtainable missing data and to ‘write off ’ such,
to minimise requests to clinicians. Feedback on improv-
ing the process is always welcomed.
Highlights from the 2014 data
Incident and prevalent rates showed no major changes
over time. Overall the prevalent population remained
largely White, male and predominantly aged .8 years,
with a functioning transplant.
Again the data shows most paediatric patients starting
RRT do so on PD, with stable pre-emptive transplant
rates. Current treatment modality is subject to variation
over time in the youngest children as they are few.
Previous reports have shown decreasing use of pre-
emptive deceased donor transplants over time [1]. In
the 2014 data, this showed a plateau in the most recent
ﬁve year periods at 10%. Pre-emptive transplantation
was observed to be inﬂuenced by ethnicity and PRD.
Structural renal disorders remained the main cause
of ERF. The proportion of glomerular disease in the
paediatric RRT population has fallen by 10% since
2000–2004. It would be interesting to know if this is
due to better treatment preserving renal function for
longer and therefore a corresponding increase in those
with earlier stages of chronic kidney disease due to
glomerular pathologies.
On the whole it would appear that most paediatric
patients start RRT without comorbidity but reporting
varied by centre. It will be useful to compare the data
before and after our data quality exercise which is further
discussed below.
A higher proportion of transplanted patients (90%)
transferred to adult services in 2014 than the previous
year (85%) which is reassuring, but these ﬁgures are
prone to ﬂuctuation due to small absolute numbers. A
project to examine the long term survival of paediatric
renal transplants in adulthood in the UK is planned to
further explore this.
Survival analysis continues to show the negative
inﬂuence of young age and dialysismodality. As in previous
years, there were few deaths in 2014; however the death of a
teenager from substance abuse highlights the likely beneﬁt
of additional psychosocial aspects to the reported paedia-
tric data. The forthcoming Surveying Patients Experiencing
young Adult Kidney failure (SPEAK) study will be collect-
ing such data on 16–30 year olds receiving RRT in the UK.
Information about the study can be found at https://www.
renalreg.org/projects/speak/.
Current and future work
In 2016, the BAPN Audit & Registry Committee will
be hosting an event for all those involved in paediatric
UKRR data, including administrative staff, managers,
information technology staff and clinicians. The aim
will be to share best practice and identify improvement
areas. The UKRR is also reviewing the support that can
be given to centres and may be able to offer a paid extrac-
tion service for paediatric centres in the future. In 2014,
only one centre was unable to provide an extract, instead
using a data collection form, and it is hoped such an event
can achieve the aim of extracts in all centres.
Centres will be contacted with the aim of completing
comorbidity and disability data for prevalent patients
Demography of renal replacement therapy
in paediatric patients
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where this may have been submitted unclearly making it
impossible to differentiate between a condition being not
present in the patient or this information not being avail-
able at the time of submission. Once complete it will be
possible to comment with more conﬁdence if there are
inter-centre differences in the rates of offering RRT to
patients with additional comorbidities.
The grouping system for PRD codes is also being
reviewed and is unique to the UKRR. These are grouped
differently to the adult Report, with many paediatric con-
ditions being lost into the broad ‘other’ adult category,
should that be used. A change now would make past
comparisons more difﬁcult but moving forwards to the
use of the most recent 2012 ERA-EDTA PRD groupings
needs to be considered. This framework uses ﬁve groups
which would lose some of the detail presented in this
report.
A UKRR project presenting data for young adults from
both adult and paediatric databases has been completed
and should achieve publication in the near future.
A signiﬁcant step towards merging new data in the
adult and paediatric databases has been made this year,
in that quarterly laboratory data has been submitted by
ten centres. This data is reported in chapter 10. Uniform
extracts and quarterly reporting will enable the loading of
new data into the adult dataset (although the historic
paediatric data will be held separately), allowing analysis
of all 16–18 year olds rather than just those reported by
paediatric centres.
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